Federal Court Grants WHOOP Preliminary Injunction Against Lexqi

Injunction orders Lexqi to halt U.S. Sales of wearable health tracker

BOSTON–(BUSINESS WIRE)–WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co., Ltd. (Lexqi). The injunction, issued in a trade dress infringement lawsuit brought by WHOOP, orders Lexqi to immediately stop selling its infringing wearable product in the United States while the litigation proceeds.

SuperKnit Luxe MG Pack Dune Gold%2C Obsidian Gold%2C Midnight Titanium %281%29
SuperKnit Luxe MG Pack Dune Gold%2C Obsidian Gold%2C Midnight Titanium %281%29
WHOOP LOGO
WHOOP LOGO

WHOOP filed the lawsuit to protect the iconic design of its wearable, described as “a continuous fabric band that wraps over the device (i.e. a faceless device) with thin metal accents on the side of the device.” In its ruling, the court said, referring to this distinctive design, that “[t]he Whoop Trade Dress has been employed by plaintiff for more than ten years, and it has been central to plaintiff’s entire business during that timeframe.” The court found that the Lexqi device “is almost identical to [the WHOOP] device that embodies the WHOOP Trade Dress.” Therefore, WHOOP demonstrated a likelihood of success on the merits of its trade dress infringement claim and that continued sales of Lexqi’s product were likely to cause consumer confusion and irreparable harm absent immediate relief.

“WHOOP members trust us with their data and rely on our technology to make meaningful decisions about their health and performance,” said Jason Lynch, Chief Administrative Officer and Chief Legal Officer of WHOOP. “Protecting our intellectual property is essential to preserving that trust. This ruling reinforces our commitment to innovation on behalf of our members and affirms the importance of respecting original technology.”

WHOOP filed suit against Lexqi in September 2025, asserting claims under the Lanham Act and related laws. The federal court’s decision reflects the importance of protecting consumers from confusion in the marketplace and ensuring that companies compete through genuine innovation rather than imitation.

WHOOP will continue to defend its intellectual property to safeguard the authenticity, quality, and integrity of the WHOOP experience as the case moves forward. The litigation is captioned WHOOP, Inc. v. Shenzhen Lexqi Electronic Technology Co., Ltd., Case No. 25-12690-FSS (D. Mass.). WHOOP is represented by Josh Dalton, Katherine Soule, and Tessa Ruff of Morgan, Lewis & Bockius.

About WHOOP:

WHOOP, the human performance company, empowers people to unlock their potential and live longer, healthier lives. The WHOOP membership delivers world-class wearable technology, personalized coaching, and actionable insights across recovery, sleep, training, and health.

WHOOP wearable devices feature groundbreaking innovations such as cardiovascular health screening (including an FDA-cleared ECG), Healthspan to measure Pace of Aging and WHOOP Age, and the first-of-its-kind wearable Blood Pressure Insights.

Founded in 2012 and headquartered in Boston, WHOOP has raised more than $400 million in venture capital and ships to 56 markets worldwide. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.

Contacts

Taylor Georgeson

[email protected]
Jack Taylor Worldwide

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.